ThinkSabio

$ACET

$3.82▼ -56.69% YTD

8 SEC 13D/G filings tracked · Last updated Oct 28, 2026

Filing History
SEC 13D/G
ACET - Adicet Bio, Inc. - SEC Filing Update (28-OCT-2026) | ThinkSabio - Stocks Simplified
$3.82▼ -56.69%Oct 28, 2026 · ThinkSabio Blog

$ACET SEC 13D/G institutional ownership filing. Healthcare sector. SEC Filing Update: #ACET Adicet Bio, Inc. : $3.82 Sector: Healthcare | YTD: 🔽 -56.6…

SEC 13D/G
ACET - Adicet Bio, Inc. - SEC Filing Update (23-OCT-2026) | ThinkSabio - Stocks Simplified
$4.03▼ -54.31%Oct 23, 2026 · ThinkSabio Blog

$ACET SEC 13D/G institutional ownership filing. Healthcare sector. SEC Filing Update: #ACET Adicet Bio, Inc. : $4.03 Sector: Healthcare | YTD: 🔽 -54.3…

News
ACET ▼ -1.0% - Adicet Bio, Inc.
CP $9.01▲ -1.0%Sep 28, 2026 · ThinkSabio Blog

$ACET Adicet Bio Announces Positive Safety and Efficacy Data from Prula-cel (formerly ADI-001) Study in Patients with Systemic Lupus Erythematosus wit…

News
ACET ▲ +20.4% - Adicet Bio, Inc.
CP $10.02▲ +20.4%Sep 25, 2026 · ThinkSabio Blog

$ACET new highs ah…

News
ACET ▲ +20.4% - Adicet Bio, Inc.
CP $10.02▲ +20.4%Sep 25, 2026 · ThinkSabio Blog

$ACET vol ah…

News
ACET ▲ +20.4% - Adicet Bio, Inc.
CP $10.02▲ +20.4%Sep 25, 2026 · ThinkSabio Blog

$ACET Adicet Bio to Host Webcast to Present Prula-cel (formerly ADI-001) Clinical Data in Patients with Systemic Lupus Erythematosus with or without L…

News
ACET ▼ -0.1% - Adicet Bio, Inc.
CP $8.72▲ -0.1%Sep 1, 2026 · ThinkSabio Blog

$ACET Adicet Bio Announces Completion of Last Patient Visit for Planned Analysis of prula-cel (formerly ADI-001) Study in Patients with Systemic Lupus…

SEC 13D/G
ACET - Adicet Bio, Inc. - SEC Filing Update (14-AUG-2026) | ThinkSabio - Stocks Simplified
$8.38▼ -4.99%Aug 14, 2026 · ThinkSabio Blog

$ACET SEC 13D/G institutional ownership filing. Healthcare sector. SEC Filing Update: #ACET Adicet Bio, Inc. : $8.38 Sector: Healthcare | YTD: 🔽 -4.99…